Bevacizumab in the treatment of ovarian cancer
Ramez N Eskander1, Leslie M Randall21Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Orange, CA, USA; 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, U...
Saved in:
Main Authors: | Ramez N Eskander, Leslie M Randall |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/eaf2adb7d17f4ca08eb11d5ecfccd55d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bevacizumab in the treatment of HER2-negative breast cancer
by: Vito Lorusso
Published: (2008) -
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
by: Jia Li, et al.
Published: (2009) -
Bevacizumab in the therapy for refractory metastatic colorectal cancer
by: Mary F Mulcahy
Published: (2008) -
Clinical utility of targeted treatments in the management of epithelial ovarian cancer
by: Twu C, et al.
Published: (2012) -
Ovarian cancer: emerging molecular-targeted therapies
by: Sourbier C
Published: (2012)